ES8602641A1 - Un procedimiento para la preparacion de nuevos antagonistas de leucotrieno. - Google Patents

Un procedimiento para la preparacion de nuevos antagonistas de leucotrieno.

Info

Publication number
ES8602641A1
ES8602641A1 ES534825A ES534825A ES8602641A1 ES 8602641 A1 ES8602641 A1 ES 8602641A1 ES 534825 A ES534825 A ES 534825A ES 534825 A ES534825 A ES 534825A ES 8602641 A1 ES8602641 A1 ES 8602641A1
Authority
ES
Spain
Prior art keywords
opt
alkyl
protected
substd
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES534825A
Other languages
English (en)
Other versions
ES534825A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lilly Industries Ltd
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of ES8602641A1 publication Critical patent/ES8602641A1/es
Publication of ES534825A0 publication Critical patent/ES534825A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/26—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton
    • C07C17/263—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by condensation reactions
    • C07C17/2635—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by condensation reactions involving a phosphorus compound, e.g. Wittig synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/35—Preparation of halogenated hydrocarbons by reactions not affecting the number of carbon or of halogen atoms in the reaction
    • C07C17/354—Preparation of halogenated hydrocarbons by reactions not affecting the number of carbon or of halogen atoms in the reaction by hydrogenation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/18—Monohydroxylic alcohols containing only six-membered aromatic rings as cyclic part
    • C07C33/20—Monohydroxylic alcohols containing only six-membered aromatic rings as cyclic part monocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/28—Alcohols containing only six-membered aromatic rings as cyclic part with unsaturation outside the aromatic rings
    • C07C33/30—Alcohols containing only six-membered aromatic rings as cyclic part with unsaturation outside the aromatic rings monocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/04—Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/14—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by free hydroxyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/32—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by aldehydo- or ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D303/40—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)

Abstract

PREPARACION DE COMPUESTOS ANTAGONISTAS DE LEUCOTRIENOS DE FORMULA (I). CONSISTENTE EN HACER REACCIONAR EL COMPUESTO (II) OBTENIDO MEDIANTE LA REACCION DE WITTIG, CON UN TIOL DE FORMULA R2-SH, SEGUIDO OPCIONALMENTE CUANDO SE DESEA PREPARAR UN COMPUESTO DONDE N ES 1 O 2, DE OXIDACION O CUANDO SE DESEA PREPARAR UN COMPUESTO DONDE R ES ALQUILO SUSTITUIDO, DE REDUCCION O DE SEPARACION DE CUALQUIER GRUPO PROTECTOR O DE INTERCONVERSION DE UN GRUPO R2, R3, R4 O R5, ELIGIENDOSE DICHOS RADICALES ENTRE GRUPOS HIDROCARBONILO OPCIONALMENTE SUSTITUIDOS, HIDROXILO, NITRILO, NITRO Y OTROS VARIOS. DE APLICACION EN TRASTORNOS ALERGICOS.
ES534825A 1983-08-03 1984-08-02 Un procedimiento para la preparacion de nuevos antagonistas de leucotrieno. Granted ES534825A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838320943A GB8320943D0 (en) 1983-08-03 1983-08-03 Organic compounds

Publications (2)

Publication Number Publication Date
ES8602641A1 true ES8602641A1 (es) 1985-12-01
ES534825A0 ES534825A0 (es) 1985-12-01

Family

ID=10546748

Family Applications (1)

Application Number Title Priority Date Filing Date
ES534825A Granted ES534825A0 (es) 1983-08-03 1984-08-02 Un procedimiento para la preparacion de nuevos antagonistas de leucotrieno.

Country Status (28)

Country Link
US (3) US4665189A (es)
EP (2) EP0134111B1 (es)
JP (1) JPS6064954A (es)
KR (1) KR920005382B1 (es)
AR (1) AR240796A1 (es)
AT (2) ATE58899T1 (es)
AU (1) AU575575B2 (es)
CA (2) CA1297632C (es)
CY (1) CY1539A (es)
DE (2) DE3483722D1 (es)
DK (1) DK167008B1 (es)
EG (1) EG16349A (es)
ES (1) ES534825A0 (es)
FI (1) FI81084C (es)
GB (2) GB8320943D0 (es)
GR (1) GR80015B (es)
HK (1) HK51090A (es)
HU (2) HU196956B (es)
IE (1) IE57691B1 (es)
IL (1) IL72539A (es)
MY (1) MY102762A (es)
NZ (1) NZ209050A (es)
PH (1) PH21029A (es)
PL (1) PL144336B1 (es)
PT (1) PT79002B (es)
SG (1) SG28590G (es)
SU (1) SU1402256A3 (es)
ZA (1) ZA845923B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143931A (en) * 1982-06-24 1992-09-01 Smithkline Beecham Corporation Leukotriene antagonists containing tetrazolyl groups
AU573774B2 (en) * 1984-02-02 1988-06-23 Vanguard, Inc. Sailboat traveler track
GB8432144D0 (en) * 1984-12-20 1985-01-30 Lilly Industries Ltd Organic compounds
GB8502258D0 (en) * 1985-01-30 1985-02-27 Lilly Industries Ltd Organic compounds
ATE90330T1 (de) * 1985-04-19 1993-06-15 Smithkline Beecham Corp Zwischenprodukte fuer die herstellung von leukotrien-antagonisten.
US4939279A (en) * 1985-04-19 1990-07-03 Smithkline Beecham Corporation Leukotriene antagonists
US4874792A (en) * 1985-04-19 1989-10-17 Smithkline Beckman Corporation Thiophenyl Alkanoic acids useful as leukotriene antagonists
US4937253A (en) * 1985-04-19 1990-06-26 Smithkline Beecham Corporation Ester prodrugs
GB8530222D0 (en) * 1985-12-07 1986-01-15 Lilly Industries Ltd Organic compounds
US4785004A (en) * 1985-12-23 1988-11-15 Ciba-Geigy Corporation Aromatic thioethers
GB8709547D0 (en) * 1987-04-22 1987-05-28 Lilly Industries Ltd Organic compounds
GB8709546D0 (en) * 1987-04-22 1987-05-28 Lilly Industries Ltd Pharmaceutical use of organic compounds
US5314918A (en) * 1987-06-24 1994-05-24 Smithkline Beecham Corporation Leukotriene antagonists
PT87616B (pt) * 1987-06-24 1992-09-30 Smithkline Beecham Corp Processo de preparacao de antagonistas do leucotrieno e de composicoes farmaceuticas
GB8725260D0 (en) * 1987-10-28 1987-12-02 Lilly Industries Ltd Organic compounds
AU610528B2 (en) * 1987-10-29 1991-05-23 Smithkline Beckman Corporation Leukotriene antagonists
GB8807016D0 (en) * 1988-03-24 1988-04-27 Lilly Industries Ltd Organic compounds & their pharmaceutical use
US5149717A (en) * 1988-03-29 1992-09-22 Ciba-Geigy Corporation Alkanophenones useful for treating allergies
JPH02134375A (ja) * 1988-09-21 1990-05-23 G D Searle & Co ３―オキシラニル安息香酸およびその誘導体
US4954513A (en) * 1988-12-23 1990-09-04 Smithkline Beecham Corporation Leukotriene antagonists
US4954520A (en) * 1989-01-19 1990-09-04 G. D. Searle & Co. 1,3-dioxolane derivatives useful in the treatment of inflammation
EP0419410A3 (en) * 1989-09-19 1991-08-14 Ciba-Geigy Ag Alkanophenones
DE69113048T2 (de) * 1990-08-01 1996-02-22 Smithkline Beecham Corp Verfahren und zwischenprodukte für die herstellung von 2-hydroxy-3-sulfido-3-phenylpropansäuren.
MY118813A (en) 1997-02-12 2005-01-31 Smithkline Beecham Corp Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
US6369226B1 (en) * 1999-06-21 2002-04-09 Agouron Pharmaceuticals, Inc. Substituted benzamide inhibitors of rhinovirus 3C protease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3649679A (en) * 1968-08-15 1972-03-14 Lilly Co Eli Substituted phenylalkanoic acid derivatives ii
GB1520812A (en) * 1975-10-02 1978-08-09 Lafon Labor Benzhydrylsulphinyl derivatives
US4513005A (en) * 1981-06-18 1985-04-23 Lilly Industries Limited SRS-A antagonists
CA1255329A (en) * 1984-10-19 1989-06-06 Mitsuru Tanemura Benzoic acid derivatives
US4755524A (en) * 1986-01-31 1988-07-05 G. D. Searle & Co. Novel phenolic thioethers as inhibitors of 5-lipoxygenase

Also Published As

Publication number Publication date
GR80015B (en) 1984-12-19
SG28590G (en) 1990-07-13
HU199457B (en) 1990-02-28
CA1301181C (en) 1992-05-19
IE841989L (en) 1985-02-03
PT79002B (en) 1986-10-23
GB8419526D0 (en) 1984-09-05
EP0201823B1 (en) 1990-12-05
EP0134111A1 (en) 1985-03-13
ES534825A0 (es) 1985-12-01
EP0201823A2 (en) 1986-11-20
FI843043A (fi) 1985-02-04
ATE58899T1 (de) 1990-12-15
DK371384D0 (da) 1984-07-31
EG16349A (en) 1987-09-30
NZ209050A (en) 1989-03-29
HUT37395A (en) 1985-12-28
SU1402256A3 (ru) 1988-06-07
IL72539A (en) 1988-12-30
DE3475516D1 (en) 1989-01-12
CY1539A (en) 1990-11-16
FI843043A0 (fi) 1984-08-01
PL144336B1 (en) 1988-05-31
HK51090A (en) 1990-07-08
US4963578A (en) 1990-10-16
US4665189A (en) 1987-05-12
DK167008B1 (da) 1993-08-16
AR240796A2 (es) 1991-02-28
GB8320943D0 (en) 1983-09-07
GB2144422B (en) 1987-12-23
JPS6064954A (ja) 1985-04-13
ZA845923B (en) 1985-04-24
IL72539A0 (en) 1984-11-30
MY102762A (en) 1992-10-31
PL249009A1 (en) 1985-03-26
EP0134111B1 (en) 1988-12-07
EP0201823A3 (en) 1987-09-16
CA1297632C (en) 1992-03-17
DE3483722D1 (de) 1991-01-17
KR920005382B1 (ko) 1992-07-02
PH21029A (en) 1987-06-30
KR850001733A (ko) 1985-04-01
FI81084C (fi) 1990-09-10
JPH058698B2 (es) 1993-02-02
FI81084B (fi) 1990-05-31
DK371384A (da) 1985-02-04
IE57691B1 (en) 1993-03-10
GB2144422A (en) 1985-03-06
PT79002A (en) 1984-08-01
AU3130484A (en) 1985-02-07
USRE33300E (en) 1990-08-14
AR240796A1 (es) 1991-02-28
ATE39110T1 (de) 1988-12-15
AU575575B2 (en) 1988-08-04
HU196956B (en) 1989-02-28

Similar Documents

Publication Publication Date Title
ES8602641A1 (es) Un procedimiento para la preparacion de nuevos antagonistas de leucotrieno.
GB2121278B (en) Oral hygiene compositions
HUT74013A (en) Polyene compounds, pharmaceutical and cosmetical compositions containing them, and use of them
ES8604571A1 (es) Un derivado de indol-3-carboxamida
ATE9059T1 (de) Ophthalmische kohlensaure anhydrase-inhibitoren enthaltende einlagen zur verringerung intraokularer hypertension.
IL66256A0 (en) Water containing compositions comprising salts of n-substituted-2-pyrrolidone-4-carboxylic acids as humectants
PE34796A1 (es) Composicion oral que comprende un nuevo tripeptido
EP0353648A3 (en) Dental antihydrolysis agent
ZA926049B (en) New 3,5 di-tert.-Butyl-4-hydroxyphenyl derivatives processes for the preparation thereof and pharmaceutical compositions containg them.
ES8506729A1 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES2125447T3 (es) Composiciones orales para tratar placa y gingivitis que contienen un agente antibacteriano no cationico y una sal bicarbonato.
FI952949A (fi) Proteiinivalmiste periodontiitiksen ja muiden suuontelon bakteerisairauksien ehkäisyyn ja terapiaan
IT1196390B (it) Uso di derivati del tiofene nel trattamento dei tumori,composizioni farmaceutiche che li contengono e composti atti allo scopo
MX170421B (es) Mejoras a composicion oral antibacterial
GR3033123T3 (en) Tricyclic derivatives, their preparation, their use in the preparation of optically active or racemic colchicine, thiocolchicine and analogues or derivatives, and intermediates
AU1495695A (en) Use of aromatic steroids substituted in position 3 by a disubstituted aminoalkyloxy chain in order to obtain a medicament intended to control fertility and in particular male fertility, and the pharmaceutical compositions containing them
ES439055A1 (es) Procedimiento para preparar derivados de la cefalosporina.
ES437197A1 (es) Procedimiento para preparar 5-feniltetrazoles sustituidos.
ES8300770A1 (es) "procedimiento para la preparacion de nuevas sales de antibioticos b-lactamicos y aminoacidos sulfurados".
ES8602785A1 (es) Procedimiento para preparar derivados de pirazolpiridina
GB1464065A (en) Salt of amoxycillin
FR2681318B1 (es)
NL7416673A (en) 3-(4-Ureido-2-acylphenoxy)-2-hydroxy-propylamines - cardioselective beta-adrenergic blocking agents
NZ218648A (en) Thiadiazoles and antiviral compositions
FR2178818A1 (en) Phenylbutazone - aminoacid salts - anti-inflammatories and analgesics

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971001